011000 진원생명과학
기본 정보
- 섹터: KOSPI:제약
- 시가총액: 485억원 (2026-06-30 기준)
- 첫 등장: 2026-06-04 (누적 1일)
- 태그: 매크로/바이오헬스 · DNA백신 · mRNA백신 · 플라스미드DNA · 바이오의약품 · 신약개발
- 네이버 금융: 🔗
기업개요
- 동사는 1976년 의류용 심지 제조를 위해 설립되고 1987년 상장했으며, 미국 DNA 백신 자회사 VGXI, Inc.와 베트남 심지 자회사를 보유하고 있음.
- 제약 사업은 바이오의약품 CDMO와 신약연구개발로 나뉘며, CDMO 사업은 VGXI, Inc.를 통해 플라스미드 DNA 핵산 원료를 생산·공급하고 있음.
- 동사는 AIMX DNA 플랫폼의 기술 통합 고도화를 추진하며, KAIST, 펜실베이니아대와 협력 연구를 진행하고 있음.
출처: 네이버증권 종목분석 (WiseReport)
일자별 등장 (최신 위, 누적)
| 일자 | 전일 종가 | 종가 | 등락률 | 시간외 | vol | 색깔 | smart | 외 | 연 | 금투 | 투 | 개 | 그외 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-08-12 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-08-11 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-08-10 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-08-07 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-08-06 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-08-05 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-08-04 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-08-03 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-31 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-30 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-29 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-28 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-27 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-24 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-23 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-22 | 2,670 | 2,670 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-21 | 534 | 2,670 | 🔴 +400.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-20 | 534 | 534 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-16 | 534 | 534 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-15 | 534 | 534 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-14 | 534 | 534 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-13 | 534 | 534 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-10 | 534 | 534 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-09 | 534 | 534 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-08 | 534 | 534 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-07 | 534 | 534 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-06 | 534 | 534 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-03 | 534 | 534 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-02 | 534 | 534 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-01 | 534 | 534 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-06-26 | 534 | 534 | ⚪ +0.00% | — | — | 🔻 개인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 | |
| 2026-06-25 | 534 | 534 | ⚪ +0.00% | — | — | 🔻 개인 | -1.4억 | -1.4 | +0.0 | +0.0 | +1.3 | +0.1 | |
| 2026-06-24 | 577 | 534 | 🔵 -7.45% | — | ×0.8 | 🔻 개인 | -1.4억 | -1.4 | +0.0 | +0.0 | +1.3 | +0.1 | |
| 2026-06-23 | 628 | 577 | 🔵 -8.12% | — | ×0.8 | 🟢 외인 | +2.1억 | +2.1 | +0.0 | +0.4 | -2.5 | -0.1 | |
| 2026-06-22 | 694 | 628 | 🔵 -9.51% | — | ×0.9 | ⚫ 그외 | -1.0억 | -1.0 | +0.0 | +0.4 | +0.1 | +0.6 | |
| 2026-06-19 | 843 | 694 | 🔵 -17.67% | — | ×1.4 | 🔻 개인 | -2.1억 | -2.1 | +0.0 | +0.0 | +1.5 | +0.5 | |
| 2026-06-18 | 885 | 843 | 🔵 -4.75% | — | ×0.4 | 🟢 외인 | +0.5억 | +0.5 | +0.0 | +0.0 | -0.6 | +0.1 | |
| 2026-06-17 | 885 | 885 | ⚪ +0.00% | — | ×0.3 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | +0.0 | -0.3 | +0.0 | |
| 2026-06-16 | 914 | 885 | 🔵 -3.17% | — | ×0.3 | 🔻 개인 | -0.7억 | -0.7 | +0.0 | +0.0 | +0.8 | -0.1 | |
| 2026-06-15 | 918 | 914 | 🔵 -0.44% | — | ×0.2 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | +0.0 | -0.3 | +0.1 | |
| 2026-06-12 | 918 | 918 | ⚪ +0.00% | — | ×0.2 | 🟢 외인 | +0.6억 | +0.6 | +0.0 | +0.0 | -0.6 | -0.1 | |
| 2026-06-11 | 917 | 918 | 🔴 +0.11% | — | ×0.3 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.1 | +0.0 | |
| 2026-06-10 | 965 | 917 | 🔵 -4.97% | — | ×0.3 | 🔻 개인 | -0.5억 | -0.5 | +0.0 | +0.0 | +0.5 | -0.0 | |
| 2026-06-09 | 980 | 965 | 🔵 -1.53% | — | ×0.3 | 🔻 개인 | -3.1억 | -3.1 | +0.0 | +0.0 | +3.1 | -0.0 | |
| 2026-06-08 | 1,085 | 980 | 🔵 -9.68% | — | ×0.3 | ⚫ 그외 | +0.0억 | +0.0 | +0.0 | +0.0 | -0.3 | +0.2 | |
| 2026-06-05 | 1,220 | 1,085 | 🔵 -11.07% | — | ×1.1 | 🔻 개인 | -26.4억 | -26.4 | +0.0 | +0.0 | +26.1 | +0.3 | |
| 2026-06-04 | 1,073 | 1,220 | 🔴 +13.70% | — | ×0.4 | 🟢 외인 | +13.0억 | +13.0 | +0.0 | +0.0 | -12.8 | -0.2 | |
| 2026-06-02 | 1,151 | 1,073 | 🔵 -6.78% | — | ×0.4 | 🔻 개인 | -2.7억 | -2.7 | +0.0 | +0.0 | +2.8 | -0.2 | |
| 2026-06-01 | 1,122 | 1,151 | 🔴 +2.58% | — | ×0.3 | 🟢 외인 | +9.4억 | +9.4 | +0.0 | +0.0 | -9.5 | +0.1 | |
| 2026-05-29 | 1,180 | 1,122 | 🔵 -4.92% | — | ×0.2 | 🔻 개인 | -2.3억 | -2.3 | +0.0 | +0.0 | +2.4 | -0.1 |
일자별 사유 (최신 위)
2026-07-21
- 사유: 콩고 에볼라 DNA백신 플랫폼 부각, 상반기 708% 급등세
- 섹터 컨텍스트: KOSPI:제약 (smart +123억)
- 매크로 원인: 코스피 3.56% 반등 속 바이오·헬스 개별 호재·상폐위기 저가주 반등이 혼재 (보통)
2026-06-04
- 사유: 불장 속 제약·바이오 상한가 행진, 공매도 베팅도 집중
- 섹터 컨텍스트: KOSPI:제약 (smart -261억)
- 매크로 원인: K-바이오 상반기 기술수출 13조원 돌파 호재로 제약·바이오 강세장 지속 (보통)